Relay Therapeutics Inc [NASDAQ: RLAY] traded at a high on Thursday, posting a 13.39 gain after which it closed the day’ session at $4.32.
The results of the trading session contributed to over 4971045 shares changing hands. Over the past one week, the price volatility of Relay Therapeutics Inc stands at 25.47% while the volatility over the past one month is 10.97%.
The market cap for RLAY stock reached $723.10 million, with 166.89 million shares outstanding and 123.45 million shares in the current float. Compared to the average trading volume of 2.14M shares, RLAY reached a trading volume of 4971045 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Relay Therapeutics Inc [RLAY]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for RLAY shares is $21.45 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on RLAY stock is a recommendation set at 1.23. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Jefferies have made an estimate for Relay Therapeutics Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on September 10, 2024. While these analysts kept the previous recommendation, Goldman raised their target price to Buy. The new note on the price target was released on September 10, 2024, representing the official price target for Relay Therapeutics Inc stock.
The Average True Range (ATR) for Relay Therapeutics Inc is set at 0.50, with the Price to Sales ratio for RLAY stock in the period of the last 12 months amounting to 72.24. The Price to Book ratio for the last quarter was 0.86, with the Price to Cash per share for the same quarter was set at 5.02.
How has RLAY stock performed recently?
Relay Therapeutics Inc [RLAY] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -10.56. With this latest performance, RLAY shares dropped by -8.28% in over the last four-week period, additionally sinking by -51.46% over the last 6 months – not to mention a drop of -60.22% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for RLAY stock in for the last two-week period is set at 46.90, with the RSI for the last a single of trading hit 47.91, and the three-weeks RSI is set at 45.66 for Relay Therapeutics Inc [RLAY]. The present Moving Average for the last 50 days of trading for this stock 4.80, while it was recorded at 4.34 for the last single week of trading, and 6.47 for the last 200 days.
Relay Therapeutics Inc [RLAY]: Deeper insight into the fundamentals
Relay Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 18.42 and a Current Ratio set at 18.42.
Insider trade positions for Relay Therapeutics Inc [RLAY]
There are presently around $98.36%, or 100.07%% of RLAY stock, in the hands of institutional investors. The top three institutional holders of RLAY stocks are: SB INVESTMENT ADVISERS (UK) LTD with ownership of 27.9 million shares, which is approximately 21.0093%. VANGUARD GROUP INC, holding 11.7 million shares of the stock with an approximate value of $$76.32 million in RLAY stocks shares; and VANGUARD GROUP INC, currently with $$68.74 million in RLAY stock with ownership which is approximately 7.9375%.
